Hydromorphone (Dilaudid) Prescribers in Louisiana
Ranked by documented Medicare Part D claim volume (2024).
126 providers in Louisiana have Medicare Part D claims for hydromorphone. Ordering reflects documented Part D claim volume — a transparency signal, not a quality or "best" ranking. Open any provider for their full profile and what they prescribe under Medicare.
hydromorphone prescribers in Louisiana
- 1View profile →
Interventional Pain Medicine Physician · Covington, LA
280 Medicare Part D claims (2024)
- 2View profile →
- 3View profile →John LedbetterM.D.
Interventional Pain Medicine Physician · Monroe, LA
114 Medicare Part D claims (2024)
- 4View profile →
- 5View profile →
- 6View profile →
Interventional Pain Medicine Physician · Baton Rouge, LA
93 Medicare Part D claims (2024)
- 7View profile →
Pain Medicine (Physical Medicine & Rehabilitation) Physician · Shreveport, LA
93 Medicare Part D claims (2024)
- 8View profile →
Interventional Pain Medicine Physician · Covington, LA
92 Medicare Part D claims (2024)
- 9View profile →
- 10View profile →John UhlM.D.
Interventional Pain Medicine Physician · Baton Rouge, LA
88 Medicare Part D claims (2024)
- 11View profile →Eric RoysterM.D.
Pain Medicine (Anesthesiology) Physician · New Orleans, LA
87 Medicare Part D claims (2024)
- 12View profile →Artemus FlaggM.D.
Pain Medicine (Anesthesiology) Physician · Slidell, LA
77 Medicare Part D claims (2024)
- 13View profile →Paul HubbellM.D.
Interventional Pain Medicine Physician · Metairie, LA
65 Medicare Part D claims (2024)
- 14View profile →John BraswellM.D.
Interventional Pain Medicine Physician · Baton Rouge, LA
62 Medicare Part D claims (2024)
- 15View profile →
- 16View profile →Mahmoud SarminiM.D.
Physical Medicine & Rehabilitation Physician · New Orleans, LA
61 Medicare Part D claims (2024)
- 17View profile →Paul KrammM.D.
Pain Medicine (Physical Medicine & Rehabilitation) Physician · Baton Rouge, LA
59 Medicare Part D claims (2024)
- 18View profile →
Interventional Pain Medicine Physician · Hammond, LA
56 Medicare Part D claims (2024)
- 19View profile →
Pain Medicine (Anesthesiology) Physician · Hammond, LA
56 Medicare Part D claims (2024)
- 20View profile →
- 21View profile →
- 22View profile →
- 23View profile →
- 24View profile →
Pain Medicine (Anesthesiology) Physician · Opelousas, LA
49 Medicare Part D claims (2024)
- 25View profile →Barrett JohnstonM.D.
Pain Medicine (Anesthesiology) Physician · Baton Rouge, LA
45 Medicare Part D claims (2024)
- 26View profile →
- 27View profile →
- 28View profile →
- 29View profile →
Pain Medicine (Anesthesiology) Physician · Bossier City, LA
37 Medicare Part D claims (2024)
- 30View profile →
- 31View profile →
Interventional Pain Medicine Physician · Shreveport, LA
35 Medicare Part D claims (2024)
- 32View profile →
- 33View profile →Michael ZeringueM.D.
Sports Medicine (Family Medicine) Physician · Metairie, LA
30 Medicare Part D claims (2024)
- 34View profile →
- 35View profile →
- 36View profile →
Pain Medicine (Anesthesiology) Physician · New Orleans, LA
29 Medicare Part D claims (2024)
- 37View profile →
- 38View profile →
- 39View profile →
- 40View profile →
- 41View profile →
- 42View profile →Yashar EshraghiM.D.
Pain Medicine (Anesthesiology) Physician · New Orleans, LA
27 Medicare Part D claims (2024)
- 43View profile →
- 44View profile →
- 45View profile →
- 46View profile →
- 47View profile →
- 48View profile →
Physical Medicine & Rehabilitation Physician · Baton Rouge, LA
24 Medicare Part D claims (2024)
- 49View profile →
- 50View profile →
Medicare Part D only. Counts and ordering reflect Medicare Part D claims (2024) from CMS — they exclude cash-pay, commercial, and Medicaid prescriptions and undercount cash-pay categories (e.g. GLP-1 weight-loss, testosterone). Not a quality or "best" ranking. Absence does not mean a provider does not prescribe hydromorphone. hydromorphone is a Schedule II controlled substance; this is a factual claims directory only — not medical advice, not an endorsement, and not instructions for obtaining any medication. Source: CMS NPPES (June 2026).